Cargando…
Fli1 Downregulation in Scleroderma Myeloid Cells Has Profibrotic and Proinflammatory Effects
Scleroderma (SSc) is an autoimmune connective tissue disease characterized by immune dysregulation, vasculopathy, and fibrosis. We have previously demonstrated that low Fli1 expression in SSc fibroblasts and endothelial cells plays an important role in SSc pathogenesis. Cells of myeloid and lymphoid...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248379/ https://www.ncbi.nlm.nih.gov/pubmed/32508810 http://dx.doi.org/10.3389/fimmu.2020.00800 |
_version_ | 1783538359975542784 |
---|---|
author | Bujor, Andreea M. El Adili, Fatima Parvez, Arshi Marden, Grace Trojanowska, Maria |
author_facet | Bujor, Andreea M. El Adili, Fatima Parvez, Arshi Marden, Grace Trojanowska, Maria |
author_sort | Bujor, Andreea M. |
collection | PubMed |
description | Scleroderma (SSc) is an autoimmune connective tissue disease characterized by immune dysregulation, vasculopathy, and fibrosis. We have previously demonstrated that low Fli1 expression in SSc fibroblasts and endothelial cells plays an important role in SSc pathogenesis. Cells of myeloid and lymphoid origin also express Fli1 and are dysregulated in patients with SSc, playing key roles in disease pathogenesis. However, the role for immune Fli1 in SSc is not yet clear. Our aim was to elucidate whether Fli1 contributes to the immune dysregulation seen in SSc. Comparison of the expression of Fli1 in monocytes, B- and T-cell fractions of PBMCs isolated from SSc patients and healthy controls (HC), showed an increase in Fli1 levels in monocytes. We used siRNA transfected human myeloid cells and mouse peritoneal macrophages obtained from Fli1(flox/flox)LysMCre(+/+) mice, and found that markers of alternative macrophage activation were increased with Fli1 deletion. Coculture of Fli1-deficient myeloid cells and primary human or mouse fibroblasts resulted in a potent induction of collagen type I, independent of TGFβ upregulation. We next analyzed global gene expression profile in response to Fli1 downregulation, to gain further insight into the molecular mechanisms of this process and to identify differentially expressed genes in myeloid cells. Of relevance to SSc, the top most upregulated pathways were hallmark IFN-γ and IFN-α response. Additionally, several genes previously linked to SSc pathogenesis and fibrosis in general were also induced, including CCL2, CCL7, MMP12, and CXCL10. ANKRD1, a profibrotic transcription co-regulator was the top upregulated gene in our array. Our results show that Fli1-deficient myeloid cells share key features with cells from SSc patients, with higher expression of profibrotic markers and activation of interferon responsive genes, thus suggesting that dysregulation of Fli1 in myeloid cells may contribute to SSc pathogenesis. |
format | Online Article Text |
id | pubmed-7248379 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72483792020-06-05 Fli1 Downregulation in Scleroderma Myeloid Cells Has Profibrotic and Proinflammatory Effects Bujor, Andreea M. El Adili, Fatima Parvez, Arshi Marden, Grace Trojanowska, Maria Front Immunol Immunology Scleroderma (SSc) is an autoimmune connective tissue disease characterized by immune dysregulation, vasculopathy, and fibrosis. We have previously demonstrated that low Fli1 expression in SSc fibroblasts and endothelial cells plays an important role in SSc pathogenesis. Cells of myeloid and lymphoid origin also express Fli1 and are dysregulated in patients with SSc, playing key roles in disease pathogenesis. However, the role for immune Fli1 in SSc is not yet clear. Our aim was to elucidate whether Fli1 contributes to the immune dysregulation seen in SSc. Comparison of the expression of Fli1 in monocytes, B- and T-cell fractions of PBMCs isolated from SSc patients and healthy controls (HC), showed an increase in Fli1 levels in monocytes. We used siRNA transfected human myeloid cells and mouse peritoneal macrophages obtained from Fli1(flox/flox)LysMCre(+/+) mice, and found that markers of alternative macrophage activation were increased with Fli1 deletion. Coculture of Fli1-deficient myeloid cells and primary human or mouse fibroblasts resulted in a potent induction of collagen type I, independent of TGFβ upregulation. We next analyzed global gene expression profile in response to Fli1 downregulation, to gain further insight into the molecular mechanisms of this process and to identify differentially expressed genes in myeloid cells. Of relevance to SSc, the top most upregulated pathways were hallmark IFN-γ and IFN-α response. Additionally, several genes previously linked to SSc pathogenesis and fibrosis in general were also induced, including CCL2, CCL7, MMP12, and CXCL10. ANKRD1, a profibrotic transcription co-regulator was the top upregulated gene in our array. Our results show that Fli1-deficient myeloid cells share key features with cells from SSc patients, with higher expression of profibrotic markers and activation of interferon responsive genes, thus suggesting that dysregulation of Fli1 in myeloid cells may contribute to SSc pathogenesis. Frontiers Media S.A. 2020-05-19 /pmc/articles/PMC7248379/ /pubmed/32508810 http://dx.doi.org/10.3389/fimmu.2020.00800 Text en Copyright © 2020 Bujor, El Adili, Parvez, Marden and Trojanowska. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Bujor, Andreea M. El Adili, Fatima Parvez, Arshi Marden, Grace Trojanowska, Maria Fli1 Downregulation in Scleroderma Myeloid Cells Has Profibrotic and Proinflammatory Effects |
title | Fli1 Downregulation in Scleroderma Myeloid Cells Has Profibrotic and Proinflammatory Effects |
title_full | Fli1 Downregulation in Scleroderma Myeloid Cells Has Profibrotic and Proinflammatory Effects |
title_fullStr | Fli1 Downregulation in Scleroderma Myeloid Cells Has Profibrotic and Proinflammatory Effects |
title_full_unstemmed | Fli1 Downregulation in Scleroderma Myeloid Cells Has Profibrotic and Proinflammatory Effects |
title_short | Fli1 Downregulation in Scleroderma Myeloid Cells Has Profibrotic and Proinflammatory Effects |
title_sort | fli1 downregulation in scleroderma myeloid cells has profibrotic and proinflammatory effects |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248379/ https://www.ncbi.nlm.nih.gov/pubmed/32508810 http://dx.doi.org/10.3389/fimmu.2020.00800 |
work_keys_str_mv | AT bujorandreeam fli1downregulationinsclerodermamyeloidcellshasprofibroticandproinflammatoryeffects AT eladilifatima fli1downregulationinsclerodermamyeloidcellshasprofibroticandproinflammatoryeffects AT parvezarshi fli1downregulationinsclerodermamyeloidcellshasprofibroticandproinflammatoryeffects AT mardengrace fli1downregulationinsclerodermamyeloidcellshasprofibroticandproinflammatoryeffects AT trojanowskamaria fli1downregulationinsclerodermamyeloidcellshasprofibroticandproinflammatoryeffects |